C11orf49

Across TCGA pan-cancer cohorts, C11orf49 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated C11orf49 data layer compared with 15 for mass-spec protein.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher C11orf49 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated C11orf49 expression acts as an unfavorable survival marker.

OV are the cancer types where C11orf49 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Median	All	0.165	0.541	.004	18	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

C11orf49–OV (DFS)

Open the OV breakdown →